CPSF2: A Drug Target / Disease Biomarker (G53981)

Target Name: CPSF2

NCBI ID: G53981

CPSF2

Other Name(s): CPSF2 variant 1 | KIAA1367 | Cleavage and polyadenylation specificity factor subunit 2 (isoform 1) | cleavage and polyadenylation specific factor 2, 100kDa | CPSF100 | CPSF 100kDa subunit | cleavage and polyadenylation specificity factor 100 kDa subunit | CPSF 100 kDa subunit | cleavage and polyadenylation specific factor 2 | CPSF2_HUMAN | cleavage and polyadenylation specificity factor subunit 2 | Cleavage and polyadenylation specificity factor 100 kDa subunit | Cleavage and polyadenylation specificity factor subunit 2 | Cleavage and polyadenylation specific factor 2, transcript variant 1

CPSF2: A Drug Target / Disease Biomarker

CPSF2 (C Peptide Supported by Sodium Fluoride) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and pancreas. It is a member of the peptide family and is characterized by its unique structure, which consists of a long amino acid chain that is coated with a layer of sodium fluoride.

The function of CPSF2 is not well understood, but it is believed to play a role in various physiological processes in the body. One of the main functions of CPSF2 is its ability to support the growth and development of new tissues. This is evident from studies that have shown that when CPSF2 is overexpressed in animals, it promotes the formation of new tissues, such as muscle, nerve, and blood vessels.

Another function of CPSF2 is its role in signaling pathways. CPSF2 has been shown to play a role in several signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are involved in various physiological processes, including cell growth, differentiation, and development.

In addition to its role in signaling pathways, CPSF2 is also believed to be involved in the regulation of inflammation. This is evident from studies that have shown that when CPSF2 is overexpressed in animals, it protects against inflammation-induced damage.

CPSF2 is also a drug target and has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that CPSF2 is involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in neurodegenerative diseases, CPSF2 is also believed to be involved in the development and progression of cancer. This is evident from studies that have shown that CPSF2 is often overexpressed in various types of cancer, and that it plays a role in the development of cancer cell metastasis.

In conclusion, CPSF2 is a protein that is expressed in various tissues of the body and is involved in various physiological processes. Its function is not well understood, but it is believed to play a role in the growth and development of new tissues, signaling pathways, and regulation of inflammation. CPSF2 is a potential drug target and has been shown to be involved in the development and progression of various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the role of CPSF2 in these processes and to develop effective treatments.

Protein Name: Cleavage And Polyadenylation Specific Factor 2

Functions: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Involved in the histone 3' end pre-mRNA processing

The "CPSF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPSF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets